Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Jun;64(3):476–483.

Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy.

S J Brett, S N Payne, J Gigg, P Burgess, R Gigg
PMCID: PMC1542453  PMID: 2431812

Abstract

The high specificity of phenolic glycolipid I (PG-I) in the identifying individuals with leprosy appears to be attributable to the species-specific trisaccharide region of the molecule. Synthetic glycoconjugates were produced by coupling the corresponding terminal mono- or disaccharide to bovine serum albumin by reductive amination. Conjugates which contained only the terminal sugar maintained in its pyranose form, the terminal disaccharide with only the terminal sugar in its pyranose form and the terminal disaccharide with both the 3,6,di-o-Me-glucose and 2,3,di-o-Me-rhamnose sugars in their pyranose forms, were all highly active in the enzyme-linked immunosorbent assay (ELISA) and showed good concordance with native PG-1 in analysis of sera from leprosy patients. The antibody levels to the glycoconjugates in tuberculosis patients and patients with other mycobacterial infections were not significantly different from the levels in normal healthy control subjects. A few of the leprosy sera showed much stronger binding to conjugates which contained the disaccharide with both sugars in the pyranose form than to conjugates with only the terminal sugar in its pyranose form. Therefore a synthetic conjugate which contains the intact disaccharide region of PG-I may provide the most sensitive antigen for the large scale serodiagnosis of leprosy.

Full text

PDF
476

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brett S. J., Draper P., Payne S. N., Rees R. J. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis. Clin Exp Immunol. 1983 May;52(2):271–279. [PMC free article] [PubMed] [Google Scholar]
  2. Brett S. J., Payne S. N., Draper P., Gigg R. Analysis of the major antigenic determinants of the characteristic phenolic glycolipid from Mycobacterium leprae. Clin Exp Immunol. 1984 Apr;56(1):89–96. [PMC free article] [PubMed] [Google Scholar]
  3. Cho S. N., Yanagihara D. L., Hunter S. W., Gelber R. H., Brennan P. J. Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy. Infect Immun. 1983 Sep;41(3):1077–1083. doi: 10.1128/iai.41.3.1077-1083.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fujiwara T., Hunter S. W., Cho S. N., Aspinall G. O., Brennan P. J. Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy. Infect Immun. 1984 Jan;43(1):245–252. doi: 10.1128/iai.43.1.245-252.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hunter S. W., Brennan P. J. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J Bacteriol. 1981 Sep;147(3):728–735. doi: 10.1128/jb.147.3.728-735.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hunter S. W., Fujiwara T., Brennan P. J. Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem. 1982 Dec 25;257(24):15072–15078. [PubMed] [Google Scholar]
  7. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  8. Ridley D. S., Waters M. F. Significance of variations within the lepromatous group. Lepr Rev. 1969 Jul;40(3):143–152. doi: 10.5935/0305-7518.19690026. [DOI] [PubMed] [Google Scholar]
  9. Schwartz B. A., Gray G. R. Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization. Arch Biochem Biophys. 1977 Jun;181(2):542–549. doi: 10.1016/0003-9861(77)90261-2. [DOI] [PubMed] [Google Scholar]
  10. Young D. B., Buchanan T. M. A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. Science. 1983 Sep 9;221(4615):1057–1059. doi: 10.1126/science.6348948. [DOI] [PubMed] [Google Scholar]
  11. Young D. B. Detection of mycobacterial lipids in skin biopsies from leprosy patients. Int J Lepr Other Mycobact Dis. 1981 Jun;49(2):198–204. [PubMed] [Google Scholar]
  12. Young D. B., Dissanayake S., Miller R. A., Khanolkar S. R., Buchanan T. M. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae. J Infect Dis. 1984 Jun;149(6):870–873. doi: 10.1093/infdis/149.6.870. [DOI] [PubMed] [Google Scholar]
  13. Young D. B., Khanolkar S. R., Barg L. L., Buchanan T. M. Generation and characterization of monoclonal antibodies to the phenolic glycolipid of Mycobacterium leprae. Infect Immun. 1984 Jan;43(1):183–188. doi: 10.1128/iai.43.1.183-188.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES